Literature DB >> 25631365

Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy.

Hye Won Lee1, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Hwang Gyun Jeon.   

Abstract

OBJECTIVES: To determine the effect of visceral obesity on the prognosis of advanced renal cell carcinoma patients undergoing nephrectomy.
METHODS: We reviewed clinicopathological data of 2187 patients who underwent nephrectomy for renal cell carcinoma (localized [T1-2, N0, M0], n = 1738 [79.5%]; advanced [T3-4, any N and M], n = 449 [20.5%]) at Samsung Medical Center, Seoul, Korea. The visceral fat area and subcutaneous fat area were determined at the level of the umbilicus on computed tomograms obtained before surgery. Patients were categorized as either viscerally obese or non-obese according to visceral fat area and visceral fat area/subcutaneous fat area ratio.
RESULTS: High visceral fat area (greater than 50 percentiles in each sex) was associated with longer cancer-specific survival (P = 0.01) or overall survival (P = 0.03), whereas visceral fat area/subcutaneous fat area ratio showed no influence on survival outcomes. By multivariate analysis adjusted with clinicopathological variables, low visceral fat area was an independent predictor of cancer-specific death and overall death (cancer-specific survival P = 0.004, hazard ratio = 2.19; overall survival P = 0.003, hazard ratio = 2.22), as well as old age (P = 0.01), radical nephrectomy (P = 0.002), high tumor grade (P = 0.01) and the presence of a sarcomatoid component (P < 0.001) in the subgroup analysis of advanced renal cell carcinoma.
CONCLUSION: High visceral fat area might represent a predictor of better prognosis in patients with advanced renal cell carcinomas undergoing nephrectomy.
© 2015 The Japanese Urological Association.

Entities:  

Keywords:  abdominal; carcinoma; nephrectomy; obesity; prognosis; renal cell

Mesh:

Year:  2015        PMID: 25631365     DOI: 10.1111/iju.12716

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  17 in total

Review 1.  The Plausibility of Obesity Paradox in Cancer-Point.

Authors:  Yikyung Park; Lindsay L Peterson; Graham A Colditz
Journal:  Cancer Res       Date:  2018-04-15       Impact factor: 12.701

Review 2.  Adiposity and cancer survival: a systematic review and meta-analysis.

Authors:  Elizabeth M Cespedes Feliciano; Bette J Caan; En Cheng; Jocelyn Kirley
Journal:  Cancer Causes Control       Date:  2022-08-15       Impact factor: 2.532

3.  Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Hisaya Shirai; Siyuan Yao; Shintaro Yagi; Naoko Kamo; Satoru Seo; Kojiro Taura; Hideaki Okajima; Shinji Uemoto
Journal:  Liver Cancer       Date:  2018-06-05       Impact factor: 11.740

4.  Visceral fat is associated with high-grade complications in patients undergoing minimally invasive partial nephrectomy for small renal masses.

Authors:  Kelan Nesbitt; Pranav Sharma
Journal:  Curr Urol       Date:  2021-03-29

5.  The effect of visceral obesity on clinicopathological features in patients with endometrial cancer: a retrospective analysis of 200 Chinese patients.

Authors:  Shuang Ye; Hao Wen; Zhaoxia Jiang; Xiaohua Wu
Journal:  BMC Cancer       Date:  2016-03-11       Impact factor: 4.430

6.  Subcutaneous adiposity is an independent predictor of mortality in cancer patients.

Authors:  Maryam Ebadi; Lisa Martin; Sunita Ghosh; Catherine J Field; Richard Lehner; Vickie E Baracos; Vera C Mazurak
Journal:  Br J Cancer       Date:  2017-06-06       Impact factor: 7.640

Review 7.  Renal cell carcinoma: links and risks.

Authors:  Reena Kabaria; Zachary Klaassen; Martha K Terris
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-03-07

8.  Clinical implication of ectopic liver lipid accumulation in renal cell carcinoma patients without visceral obesity.

Authors:  Daisuke Watanabe; Akio Horiguchi; Shinsuke Tasaki; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Keiichi Ito; Tomohiko Asano; Hiroshi Shinmoto
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

9.  The association between renal sinus fat area and the progression-free survival in Chinese non-metastatic clear-cell renal cell carcinoma patients.

Authors:  Haichao Huang; Shi Chen; Wei Yu; Zirong Ye; Wei Li; Jinchun Xing; Xiurong Wu
Journal:  Oncotarget       Date:  2017-07-05

10.  Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.

Authors:  Yeonjung Ha; Daejung Kim; Seungbong Han; Young Eun Chon; Yun Bin Lee; Mi Na Kim; Joo Ho Lee; Hana Park; Kyu Sung Rim; Seong Gyu Hwang
Journal:  Cancer Res Treat       Date:  2017-09-04       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.